Results 201 to 210 of about 67,931 (327)

Echocardiographic assessment of a novel blood-guiding accessory for left ventricular assist devices in swine. [PDF]

Interdiscip Cardiovasc Thorac Surg
Galbas MC, Meissner F, Straky H, Reuter J, Schimmel M, Czerny M, Bothe W.   +6 more
europepmc   +1 more source

The influence of left ventricular assist device inflow cannula position on thrombosis risk [PDF]

, 2020
Mojgan Ghodrati, Alexander Maurer, Thomas Schlöglhofer, Thananya Khienwad, Daniel Zimpfer, Dietrich Beitzke, Francesco Zonta, Francesco Moscato, Heinrich Schima, Philipp Aigner   +9 more
openalex   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

Hemodynamic analysis of the aortic root based on differences in outflow graft angle in patients with implantable left ventricular assist devices. [PDF]

J Artif Organs
Yamamoto H, Kohno H, Ikeuchi H, Kanda T, Watanabe M, Inui T, Matsuura K, Matsumiya G.   +7 more
europepmc   +1 more source

eGFR slope as predictor of mortality in heart failure patients

ESC Heart Failure, Volume 12, Issue 2, Page 1217-1226, April 2025.
Abstract Aims Heart failure (HF) leads to an imbalance between heart and kidney function, resulting in poor outcomes. However, the prognostic significance of the estimated glomerular filtration rate (eGFR) trajectory in HF patients remains unclear. We analysed electronic health records (EHRs) of real‐world HF patients, assessing eGFR trajectories and ...
Sofie Verstreken, Monika Beles, Clara L. Oeste, Ana Moya, Imke Masuy, Riet Dierckx, Ward Heggermont, Jeroen Dauw, Dries Hens, Jozef Bartunek, Marc Vanderheyden   +10 more
wiley   +1 more source

Impact of age, sex, therapeutic intent, race and severity of advanced heart failure on short-term principal outcomes in the MOMENTUM 3 trial [PDF]

, 2018
et al,, Itoh, Akinobu
core   +1 more source

Diaphragm Training in Patients With Left Ventricular Assist Devices: A Narrative Review of Rehabilitation and Clinical Implications. [PDF]

Cureus
Bordoni B, Morabito B, Escher AR.
europepmc   +1 more source

Diagnosis of LVAD thrombus using a high-avidity fibrin-specific 99mTc probe [PDF]

, 2018
Akinobu Itoh, Anne H. Schmieder, Dmitry D. Beyder, Grace Cui, Gregory A. Ewald, Gregory M. Lanza, John S. Allen, Krishna S. Paranandi, Michael J. Scott, Michael Nassif, Samuel Achilefu, Walter J. Akers   +11 more
core   +2 more sources

Myocardial inflammation is associated with impaired mitochondrial oxidative capacity in ischaemic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1246-1255, April 2025.
Abstract Aims Myocardial inflammation and impaired mitochondrial oxidative capacity are hallmarks of heart failure (HF) pathophysiology. The extent of myocardial inflammation in patients suffering from ischaemic cardiomyopathy (ICM) or dilated cardiomyopathy (DCM) and its association with mitochondrial energy metabolism are unknown.
Julius Borger, Elric Zweck, Constanze Moos, Patrick Horn, Fabian Voß, Heinz‐Peter Schultheiss, Jacob Eifer Møller, Udo Boeken, Hug Aubin, Artur Lichtenberg, Malte Kelm, Michael Roden, Amin Polzin, Ralf Westenfeld, Julia Szendroedi, Daniel Scheiber   +15 more
wiley   +1 more source

Signal artefacts in wearable-based biosignal acquisition in patients with ventricular assist devices: the SMART-VADCH trial. [PDF]

Eur Heart J Digit Health
Heil E, Roehrich L, Reichert L, Just IA, Hindricks G, Schoenrath F, Hohendanner F.   +6 more
europepmc   +1 more source